You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site.

Continue

Go back

Our vaccines portfolio

Arexvy

Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted)

Bexsero

Meningococcal group B vaccines (rDNA, component, adsorbed)

Boostrix

Diphtheria, tetanus and pertussis
(acellular, component) vaccine
(adsorbed, reduced antigen(s) content)

Engerix B 20mcg (Adult)

Hepatitis B (rDNA) vaccine (adsorbed) (HBV)

Fendrix

Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)

Havrix Monodose

Hepatitis A vaccine
(inactivated, adsorbed)

Havrix Junior Monodose

Hepatitis A vaccine
(inactivated, adsorbed)

Hiberix

Haemophilus Type b (Hib) vaccine

Infanrix Hexa

Diphtheria (D), tetanus (T),
pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (adsorbed)

Menitorix

Haemophilus type b and Meningococcal group C conjugate vaccine

Menjugate

Meningococcal group C conjugate vaccine

Priorix

Measles, Mumps and Rubella vaccine (live)

Rotarix

rotavirus vaccine, live

Shingrix

Herpes zoster vaccine (recombinant, adjuvanted)

Twinrix (Adult)

Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.

Arexvy, Bexsero, Boostrix, Engerix B, Fendrix, Havrix, Hiberix, Infanrix Hexa, Menitorix, Menjugate, Priorix, Rotarix, Shingrix and Twinrix are registered trademarks of the GlaxoSmithKline Group of Companies.